In one of several deals that energized markets yesterday, Abbott Laboratories (ABT)said it would pay $6.6 billion for the pharmaceutical business of Belgian chemicals maker Solvay.
The deal is the latest in a string of drug mergers and acquisitions, and one of three announcements yesterday that involved the fast-growing vaccines business.
Also yesterday, Johnson & Johnson Inc. bought an 18 percent stake in the Dutch biotechnology company Crucell NV, which is trying to develop a universal flu vaccine, while competitor Merck & Co. Inc. acquired the rights to sell Australia-based CSL Ltd.'s Afluria flu vaccine in the United States.
By purchasing Brussels-based Solvay, Abbott gains access to emerging markets in Eastern Europe and Asia along with new therapeutic areas, including hormone therapies and vaccines.
Solvay's flu vaccine Influvac gives Abbott an entrant in the burgeoning vaccines market, which is dominated by European pharmaceutical giants such as GlaxoSmithKline and Novartis.
http://www.philly.com/inquirer/business/20090929_Pharma-deal_flurry_ignites_stocks.html
Tuesday, September 29, 2009
Monday, September 21, 2009
Dell to Buy Perot Systems September-21-2009
Dell agrees to buy Perot Systems for about $3.9B
Dell to buy Perot Systems for about $3.9B in cash, taking another step beyond the PC market
$16.69 -0.17 (1.01%) 52Wk Range: 7.84 - 18.44
http://finance.yahoo.com/news/Dell-agrees-to-buy-Perot-apf-3148015079.html?x=0&sec=topStories&pos=main&asset=&ccode=.
@@@
http://infodumy.blogspot.com/
Subscribe to:
Posts (Atom)